Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Abroad (travel likely)RecruitingPHASE1, PHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Advanced Solid Malignancies
Locations
- Research Site, La Jolla, California, United States
- Research Site, Los Angeles, California, United States
- Research Site, San Francisco, California, United States
- Research Site, Chicago, Illinois, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, New York, New York, United States
- Research Site, New York, New York, United States
- Research Site, Portland, Oregon, United States
- Research Site, Houston, Texas, United States
- Research Site, San Antonio, Texas, United States
- Research Site, Richmond, Virginia, United States
- Research Site, Camperdown, Australia
- Research Site, Darlinghurst, Australia
- Research Site, Melbourne, Australia
- Research Site, Randwick, Australia
- Research Site, Bayern, Germany
- Research Site, Berlin, Germany
- Research Site, Heidelberg, Germany
- Research Site, Mainz, Germany
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, A Coruña, Spain
- Research Site, Barcelona, Spain
- Research Site, Málaga, Spain
- Research Site, Pozuelo de Alarcón, Spain
- Research Site, Sant Cugat del Vallès, Spain
- Research Site, Seville, Spain
- Research Site, Lund, Sweden
- Research Site, Stockholm, Sweden
- Research Site, Glasgow, Scotland, United Kingdom
- Research Site, London, United Kingdom
- Research Site, Newcastle upon Tyne, United Kingdom